Insider · CIK 0001465278

Hagan Joseph P

Reports to the SEC for 4 companies · LA JOLLA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001465278

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-06-25	Regulus Therapeutics Inc.D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−572K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−6,500 sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−1,000 sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−100K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−90K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−160K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−30K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−100K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−1.31M sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−249K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−990K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−1.35M sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Common Stock Purchase Warrant (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−2,976 sh	—	—	0
2025-01-30	Regulus Therapeutics Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+50K sh	$1.09	+$54.3K	260,808
2025-01-30	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+1.35M sh	—	—	1,350,000
2025-01-14	Regulus Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−11.8K sh	$1.26	−$14.9K	210,808
2025-01-13	Regulus Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−115K sh	$1.26	−$146K	222,572
2025-01-09	Regulus Therapeutics Inc.A Award	Director, Chief Executive Officer	AAward	+219K sh	$1.36	+$298K	275,862
2025-01-09	Regulus Therapeutics Inc.A Award	Director, Chief Executive Officer	AAward	+62K sh	$1.30	+$80.6K	337,862
2024-05-20	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+990K sh	—	—	990,000
2024-01-18	Regulus Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−14.6K sh	$1.19	−$17.4K	57,112
2024-01-12	Regulus Therapeutics Inc.A Award	Director, Chief Executive Officer	AAward	+30K sh	—	—	71,692
2024-01-12	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+249K sh	—	—	249,000
2023-08-10	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+1.31M sh	—	—	1,312,500
2023-05-19	AUPHAurinia Pharmaceuticals Inc.S Sale	Director	SSale	−272 sh	$10.58	−$2,877.76	11,961
2023-05-18	AUPHAurinia Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+8,733 sh	—	—	12,233
2023-05-18	AUPHAurinia Pharmaceuticals Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−8,733 sh	—	—	0
2023-01-11	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+100K sh	—	—	100,000
2022-05-18	AUPHAurinia Pharmaceuticals Inc. · Restricted Stock UnitA Award	Director	AAward	+8,733 sh	—	—	8,733
2022-05-18	AUPHAurinia Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director	AAward	+14.6K sh	—	—	14,612
2022-05-10	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+300K sh	—	—	300,000
2022-01-26	Regulus Therapeutics Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+100K sh	$0.22	+$21.5K	417,006
2022-01-12	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+1.6M sh	—	—	1,600,000
2022-01-03	AUPHAurinia Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+40K sh	$5.08	+$203K	43,500
2022-01-03	AUPHAurinia Pharmaceuticals Inc.S Sale	Director	SSale	−39.4K sh	$22.58	−$889K	4,134
2022-01-03	AUPHAurinia Pharmaceuticals Inc.S Sale	Director	SSale	−634 sh	$23.29	−$14.8K	3,500
2022-01-03	AUPHAurinia Pharmaceuticals Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−40K sh	—	—	10,000
2021-06-14	AUPHAurinia Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director	AAward	+31.3K sh	—	—	31,347
2021-06-10	Zosano Pharma CorpA Award	Director	AAward	+15K sh	—	—	22,500
2021-06-10	Zosano Pharma CorpStock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2021-05-17	Regulus Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−4,186 sh	$0.89	−$3,725.54	316,292
2021-04-14	Regulus Therapeutics Inc.C Conversion	Director, Chief Executive Officer	CConversion	+75.9K sh	—	—	320,478
2021-04-14	Regulus Therapeutics Inc.Class A-2 Convertible Preferred StockC Conversion	Director, Chief Executive Officer	CConversion	+7,585 sh	—	—	0
2021-02-16	Regulus Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−4,144 sh	$1.72	−$7,127.68	244,628
2021-02-16	Regulus Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−4,144 sh	$1.72	−$7,127.68	485,756
2021-02-04	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+600K sh	—	—	600,000
2020-12-04	Regulus Therapeutics Inc.A Award	Director, Chief Executive Officer	AAward	+39.7K sh	$0.63	+$25K	225,674
2020-12-04	Regulus Therapeutics Inc.Common Stock Purchase Warrant (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+29.8K sh	$0.13	+$3,720	29,760
2020-11-16	Regulus Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−6,094 sh	$0.52	−$3,175.583	215,994
2020-08-14	Regulus Therapeutics Inc.S Sale	Director, Chief Executive Officer	SSale	−4,245 sh	$0.60	−$2,567.801	222,088

Recent filings

Accepted (ET)
Jun 274
Hagan Joseph P0000950170-25-091015
SEC(opens sec.gov)
Jan 314
Hagan Joseph P0000950170-25-011853
SEC(opens sec.gov)
Jan 154
Hagan Joseph P0000950170-25-005883
SEC(opens sec.gov)
Jan 104
Hagan Joseph P0000950170-25-004274
SEC(opens sec.gov)
May 214
Hagan Joseph P0000950170-24-062920
SEC(opens sec.gov)

Companies

Address

C/O OREXIGEN THERAPEUTICS, INC. 3344 N. TORREY PINES COURT, SUITE 200

LA JOLLA, CA, 92037